Rubicon Research Ltd.

₹1845

+ 54.45 (3.04%)

04:01 pm - close price

BSE: RUBICON

NSE: RUBICON

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 14.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 14.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.22Good: 20

✅

Current Ratio

Bad: 1Current: 2.01Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 27.84Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.21Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 14.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 14.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.22Good: 20

✅

Current Ratio

Bad: 1Current: 2.01Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 27.84Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.21Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	3135.67	3935.19	85388.91	12842.72	17539.56
Operational Expenses+	3527.99	3750.27	69929.71	10283.26	13546.94
Operating Profit	-392.32	184.92	15459.20	2559.46	3992.62
Other Income	168.50	254.80	1849.66	119.47	87.02
OPM %	-12.51	4.70	18.10	19.93	22.76
Depreciation and Amortisation	340.07	360.61	3897.26	365.88	452.62
Interest	97.23	189.60	3125.88	367.82	421.68
Profit Before Tax	-661.12	-110.49	10285.72	1945.23	3205.34
Tax	47.16	58.39	1179.73	590.82	738.26
Net Profit	-671.18	-168.88	9101.22	1343.61	2467.35

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	5595.18	7497.04	110856.35	14496.61	23137.05
Liabilities+	5595.18	7497.04	110856.35	14496.61	23137.05

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	-626.34	-747.49	2101.03	1591.77	2050.46
Cash from Investing Activity	-549.20	-338.21	-6851.43	-648.09	-4097.23
Cash from Financing Activity	630.51	1228.14	4355.33	-398.10	2830.67
Net Cash Flow	-545.03	142.44	-395.07	545.58	783.90
Opening Cash & Cash Equivalents	841.61	386.71	5442.66	506.04	1049.77
Closing Cash & Cash Equivalents	386.71	544.27	5060.49	1049.77	1856.54

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	OCT'25	MAR'23	MAR'22	MAR'21	MAR'20	AUG'19	SEP'18
Promoters+	59.76	59.86	59.99	59.99	8.46	8.46	8.46	8.46	27.67	27.67
Public+	40.24	40.14	40.01	40.01	91.54	91.54	91.54	91.54	72.33	72.33
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	43254	33738	31914	105311	15	15	15	0	13	13

Corporate Actions

95 events in the last 3 years

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	3135.67	3935.19	85388.91	12842.72	17539.56
Operational Expenses+	3527.99	3750.27	69929.71	10283.26	13546.94
Operating Profit	-392.32	184.92	15459.20	2559.46	3992.62
Other Income	168.50	254.80	1849.66	119.47	87.02
OPM %	-12.51	4.70	18.10	19.93	22.76
Depreciation and Amortisation	340.07	360.61	3897.26	365.88	452.62
Interest	97.23	189.60	3125.88	367.82	421.68
Profit Before Tax	-661.12	-110.49	10285.72	1945.23	3205.34
Tax	47.16	58.39	1179.73	590.82	738.26
Net Profit	-671.18	-168.88	9101.22	1343.61	2467.35

Ratios

Reported EPS

Bad: 2Current: 14.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 14.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.22Good: 20

✅

Current Ratio

Bad: 1Current: 2.01Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 27.84Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.21Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 14.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 14.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.22Good: 20

✅

Current Ratio

Bad: 1Current: 2.01Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 27.84Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.21Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	-626.34	-747.49	2101.03	1591.77	2050.46
Cash from Investing Activity	-549.20	-338.21	-6851.43	-648.09	-4097.23
Cash from Financing Activity	630.51	1228.14	4355.33	-398.10	2830.67
Net Cash Flow	-545.03	142.44	-395.07	545.58	783.90
Opening Cash & Cash Equivalents	841.61	386.71	5442.66	506.04	1049.77
Closing Cash & Cash Equivalents	386.71	544.27	5060.49	1049.77	1856.54

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	OCT'25	MAR'23	MAR'22	MAR'21	MAR'20	AUG'19	SEP'18
Promoters+	59.76	59.86	59.99	59.99	8.46	8.46	8.46	8.46	27.67	27.67
Public+	40.24	40.14	40.01	40.01	91.54	91.54	91.54	91.54	72.33	72.33
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	43254	33738	31914	105311	15	15	15	0	13	13

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	5595.18	7497.04	110856.35	14496.61	23137.05
Liabilities+	5595.18	7497.04	110856.35	14496.61	23137.05

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Corporate Actions

95 events in the last 3 years

Rubicon Research Ltd.

₹1845

+ 54.45 (3.04%)

04:01 pm - close price

BSE: RUBICON

NSE: RUBICON

Industry: Pharmaceuticals & Drugs

House: Private

Overview